NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-020-2013-0-FR-06 Compositions and Methods for Detecting Neoplasia FR EP 14704237.8 Abandoned
NCI E-020-2013-0-DE-05 Compositions and Methods for Detecting Neoplasia DE EP 14704237.8 Abandoned
NCI E-020-2013-0-GB-07 Compositions and Methods for Detecting Neoplasia GB EP 14704237.8 Abandoned
NCI E-020-2013-0-PCT-02 Compositions and Methods for Detecting Neoplasia PCT PCT PCT/US2014/012758 Expired
NHGRI E-039-2014-0-US-01 Compounds and Method for Treating PARP1-Deficient Cancers US 61/930,291 Abandoned
NIDDK E-761-2013-0-US-01 cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY US 61/929,893 Abandoned
NIA E-279-2013-0-US-01 METHOD FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS US 61/929,659 Abandoned
NCI E-162-2009-0-AU-08 Pharmaceutical Compositions which Inhibit Of FKBP52-Mediated Regulation Of Androgen Receptor Function And Methods of Using Same AU DIV 2014200360 Abandoned
NCI E-117-2011-0-US-22 Recombinant Immunotoxin Targeting Mesothelin US National Stage 14/115,131 10683362 Issued PDF
NCI E-168-2011-0-US-07 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology US National Stage 14/233,582 9764022 Issued PDF
NCI E-168-2011-0-JP-06 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology JP National Stage 2014-521716 Issued
NCI E-168-2011-0-CA-04 Methods and Compositions For Inhibiting Polyomavirus-Associated Pathology CA National Stage 2842180 Issued
NIAID E-133-2012-0-PCT-02 Attenuated Chlamydia Vaccine PCT PCT PCT/US2014/011799 Expired
NICHD E-304-2008-0-US-03 Vaccine Against Influenza Virus US DIV 14/157,417 Abandoned
NIAMS E-216-2010-0-US-06 Compositions and Methods for Treating or Preventing Lupus US National Stage 13/989,744 9657292 Issued PDF
NCI E-243-2002-1-US-08 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using the Same US DIV 14/156,105 Abandoned
NICHD E-003-2014-0-US-01 Cartilage Targeting Agents And Their Use US 61/927,904 Abandoned
NCI E-003-2007-0-AU-16 Engineered Antibody Constant Domain Molecules AU DIV 2014200215 Issued
NIA E-089-2009-0-US-04 SPANX-B POLYPEPTIDES AND THEIR USE US DIV 14/155,230 9238684 Issued PDF
NIAID E-010-2014-0-US-01 MALARIA TRANSMISSION BLOCKING VACCINES US 61/927,166 Abandoned
NIDCR E-087-2011-0-US-04 AAV Mediated CTLA-4 Gene Transfer to Treat Sjogren's Syndrome US National Stage 14/111,604 Abandoned
NCI E-295-2012-0-US-01 Anti-Viral Cnidarins US 61/925,347 Abandoned
NCI E-205-2010-2-SG-07 Photosensitizing Antibody-Flurophore Conjugates SG National Stage 2013091822 Issued
NCI E-141-2008-0-JP-16 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof JP DIV 2014-001373 Abandoned
NCI E-062-2014-0-US-01 RAS Pathways As Markers Of Protection Against HIV And Means To Improve Vaccine Efficacy US 61/925,154 Abandoned
NHLBI E-758-2013-0-US-01 Antibody Targeting Cell Surface Deposited Complement Protein C3d and Use Thereof US 61/924,967 Abandoned
CC E-063-2011-0-US-03 Radiographic Marker That Displays An Angle In Degrees On Portable X-Rays US National Stage 14/005,024 9541822 Issued PDF
NCI E-254-2005-2-JP-19 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENE EXPRESSION IN MAMMALIAN CELLS JP DIV 2014-000118 Issued
NHLBI E-183-2004-1-JP-09 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS JP DIV 2014-000536 Abandoned
NIAID E-043-2014-0-US-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US 61/923,546 Abandoned
NIDCR E-308-2003-3-US-03 METHODS OF DIAGNOSING AND TREATING HYPERPROLIFERATIVE DISORDERS US CON 14/146,387 Abandoned
NHGRI E-324-2001-0-US-05 METHODS FOR ANALYZING HIGH DIMENSIONAL DATA FOR CLASSIFYING DIAGNOSING PROGNOSTICATING AND/OR PREDICTING DISEASES AND OTHER BIOLOGICAL STATES US CON 14/143,572 Abandoned
NIA E-088-2007-1-US-09 METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION US CON 14/143,568 Abandoned
NIAID E-050-1997-1-US-20 Method Of Sampling, Amplifying And Quantifying Segment Of Nucleic Acid US CON 14/142,488 Abandoned
NIAID E-531-2013-1-US-01 NOVEL EPSTEIN-BARR VIRUS VACCINES US 61/921,284 Abandoned
NCATS E-043-2013-0-PCT-02 Inhibitors of the USP1/UAF1 Deubiquitinase Complex and Uses Thereof PCT PCT PCT/US2013/077804 Expired
NCATS E-043-2013-0-EP-05 Inhibitors of the USP1/UAF1 Deubiquitinase Complex and Uses Thereof EP National Stage 13821618.9 Abandoned
NCATS E-043-2013-0-AU-03 Inhibitors of the USP1/UAF1 Deubiquitinase Complex and Uses Thereof AU National Stage 2013370417 Abandoned
NCATS E-043-2013-0-CA-04 Inhibitors of the USP1/UAF1 Deubiquitinase Complex and Uses Thereof CA National Stage 2896731 Abandoned
NCI E-074-2007-0-US-13 Brachyury Polypeptides and Methods for Use US CON 14/138,629 Abandoned
NINDS E-143-2002-0-US-13 Zenapax (Humanized Antibody Against the IL-2 Receptor Alpha Chain) As A Novel Treatment for Multiple Sclerosis US CON 14/139,424 Abandoned
NHLBI E-241-2010-0-US-04 CAPSID-FREE AAV VECTORS, COMPOSITIONS, AND METHODS FOR VECTOR PRODUCTION AND GENE DELIVERY US National Stage 14/004,379 9598703 Issued PDF
NIAID E-232-2004-4-US-10 Compositions And Methods For Generating An Immune Response US DIV 14/137,095 9254319 Expired PDF
NCI E-312-2005-0-US-05 Immunogenic Peptides and Methods of Use for Treating and Preventing Cancer US DIV 14/136,124 9206245 Abandoned PDF
NEI E-089-2011-0-US-01 Conjugates For Treating Inflammatory Disease and Identification of Patients Likely to Benefit from such Treatment US 61/919,404 Abandoned
NCI E-549-2013-0-US-01 IMMUNOGENIC JC POLYOMAVIRUS COMPOSITIONS AND METHODS OF USE US 61/919,043 Abandoned
NCI E-003-2007-0-CA-04 Engineered Antibody Constant Domain Molecules CA National Stage 2713281 Issued
NIAID E-124-2009-0-MX-14 Influenza Hemagglutinin And Neuraminidase Variants MX DIV MX/a/2013/015094 Abandoned
NICHD E-061-2005-0-US-05 A Novel Marker For Cardiomyocyte Progenitor Cells US CON 14/107,235 Abandoned
NCI E-050-2014-0-US-01 Cancer Immunotherapy By Delivering Class II MHC Antigens Using a VLP Replicon US 61/916,394 Abandoned